Recipharm Appoints New General Manager
News Apr 30, 2015
Recipharm has announced that Giorgio Bruno has been appointed General Manager of Recipharm Italia S.p.A. In this role, he will serve as CEO for all of Recipharm’s Italian operating companies which employ some 257 people at three sites and have revenues of €57m.
Dr Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. He has worked in both Italian and multinational pharmaceutical companies covering a wide range of disciplines.
In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. Dr Bruno also has strong industry knowledge and has held a number of positions within Italian based industry associations. He holds a Ph. D. in Pharmaceutical Chemistry and Technology from the University of Milan.
“Commenting on the appointment, Thomas Eldered, CEO of Recipharm remarked: “I am very pleased to welcome Dr Bruno to the Recipharm team. We are very fortunate to have been able to attract such a competent and highly experienced manager to this important position and I look forward to him bringing his expertise to bear across our Italian operations for which he is now responsible.”
Synthetic biologists look to re-engineer cells to make complex molecules for specific needs, including pharmaceuticals. But the trial-and-error process is difficult and time-consuming. Now, by combining two state-of-the-art research approaches, researchers have created a fast, efficient way to engineer and analyze metabolic pathways.READ MORE